about
Pharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporterProfiles of multidrug resistance protein-1 in the peripheral blood mononuclear cells of patients with refractory epilepsyLinkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur HospitalDevelopment of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrateThe Alterations in the Expression and Function of P-Glycoprotein in Vitamin A-Deficient Rats as well as the Effect of Drug Disposition in VivoIn situ labeling and imaging of endogenous neural stem cell proliferation and migration.Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.In situ localization of P-glycoprotein (ABCB1) in human and rat brainSpatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in RatsDelivering non-hormonal contraceptives to men: advances and obstacles.ABCB1 genetic variants in leukemias: current insights into treatment outcomesATP-binding cassette transporters modulate both coelenterazine- and D-luciferin-based bioluminescence imagingIn vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide.Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.Multilayer spheroids to quantify drug uptake and diffusion in 3D.Drug resistance in brain diseases and the role of drug efflux transporters.Evaluation of [C]S14506 and [F]S14506 in rat and monkey as agonist PET radioligands for brain 5-HT(1A) receptors.Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrierProbing the stereoselectivity of P-glycoprotein-synthesis, biological activity and ligand docking studies of a set of enantiopure benzopyrano[3,4-b][1,4]oxazines.Drug transporters in spermatogenesis: A re-evaluation of recent data on P-glycoproteinThe Role of P-Glycoprotein in Transport of Danshensu across the Blood-Brain Barrier.Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.ABC multidrug transporters: structure, function and role in chemoresistance.Emerging role for drug transporters at the blood-testis barrierValidated LC-MS method for simultaneous quantitation of catalpol and harpagide in rat plasma: application to a comparative pharmacokinetic study in normal and diabetic rats after oral administration of Zeng-Ye-Decoction.Impact of ABCB1 allelic variants on QTc interval prolongation.ATP-binding cassette efflux transporters in human placenta.ATP-binding cassette transporters are required for efficient RNA interference in Caenorhabditis elegansVery important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Drug transporters, the blood-testis barrier, and spermatogenesisInteraction of innovative small molecule drugs used for cancer therapy with drug transporters.Tailored delivery of analgesic ziconotide across a blood brain barrier model using viral nanocontainers.Reproducibility of quantitative (R)-[11C]verapamil studies.Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsABCB1 genotype and CSF beta-amyloid in Alzheimer diseaseCoadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide.Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice.Determinants of Gefitinib toxicity in advanced non-small cell lung cancer (NSCLC): a pharmacogenomic study of metabolic enzymes and transporters.Modulation of p-glycoprotein transport function at the blood-brain barrier.
P2860
Q28480949-54700C1B-3D1A-45DE-B3A5-596A6EC3D4B5Q28483667-CA47E6A7-D109-451F-A004-3C6A1A5AAB52Q28533307-B3C148D3-7F4B-4270-A4AD-8B3454EA04CFQ28535627-42198EF4-224A-4225-9B85-B2F8BA5AEB4FQ28571953-8D8897C1-5004-4DDE-9202-295C5874A487Q30559846-8CB1F72A-ED71-4EC2-A560-B3F2FBB45039Q30571118-ED123ED5-E882-44BA-B620-0EB0CF0719A0Q33248008-DCF79D55-9542-4D1B-A2D9-0FF943D890D1Q33583533-0406ADF3-09C2-439B-A52B-B6D2575E5B99Q33674046-F6DF85C2-06B5-493B-9537-B3819E5A43DDQ33707782-D8F208F9-3AD1-47DE-9F73-BCFF3994AF0DQ33738298-8D16E679-8080-4B59-9E80-C2DEAB472235Q33768138-D66C631D-5776-403F-ACE7-F34A1BE183C1Q33797745-D1ACF1AB-B4E9-4B04-A2D5-0F4FE82D009AQ33857581-9C1C1214-C44A-40E7-9FA3-C8F3DD59E3CFQ33894623-387229FC-49B8-4CB9-B491-5CCB9C713FE3Q33988704-2477D054-302E-4E41-91BD-D7398A6D6846Q34011564-71A7E6F2-B20F-4C53-91B2-4CEFBC525C08Q34075276-5C8BBB94-E5AB-4C89-89D0-F079066A4804Q34155954-A81D19DB-93CC-4BD9-8004-D2AC3852CC92Q34293827-23E880C6-E95C-442F-83BB-FB87D78F3302Q34557586-6790A515-3B64-4F12-8CF7-5F63BA23BC61Q34568808-C711007E-7AEE-4AEF-BD22-635235E63694Q34586418-62BE9798-221C-4B43-AAEA-95F32B8D40D2Q34640153-A70BFBE7-6BB4-4ACF-B828-13B4C80F9860Q34765139-8F47F84A-0DE7-4E22-965C-D248F90F552CQ34781769-9CCEBDE7-A815-4712-B25A-FFCDD4DFCE8EQ34843023-45710C49-2ABD-40DD-8198-CCFC46479F12Q34886289-4AE76226-28EF-49CE-98D8-1C2A261B99BEQ34994901-5CC55481-BC63-4CF5-BA57-C02DD6982679Q35240133-F3E0229F-6279-4CF7-A74B-7E09A8177DDBQ35708124-5FBBF356-9AEF-479C-932F-8A421EF82AE0Q35733724-15752794-AA22-4BD0-BBFA-5D3366754092Q35742284-A7820E8C-181A-4841-B288-B407C534F720Q35795744-911583B5-89AC-4EB0-A35C-4ACE313E9D90Q35801727-2E021168-82F9-492B-83B6-E3CC68888812Q35827146-5C638C7B-4E3E-4E61-951A-4A3E2DFCD27CQ35860275-0C899B7B-95DC-49EC-9A9F-66D2F71B8176Q35992745-B96C4BF1-E4D4-44C0-86D3-E3F72E73A725Q36021258-758D0676-6C2A-4882-94D9-D36B8C0DE289
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Importance of P-glycoprotein at blood-tissue barriers.
@ast
Importance of P-glycoprotein at blood-tissue barriers.
@en
type
label
Importance of P-glycoprotein at blood-tissue barriers.
@ast
Importance of P-glycoprotein at blood-tissue barriers.
@en
prefLabel
Importance of P-glycoprotein at blood-tissue barriers.
@ast
Importance of P-glycoprotein at blood-tissue barriers.
@en
P1476
Importance of P-glycoprotein at blood-tissue barriers.
@en
P2093
Martin F Fromm
P304
P356
10.1016/J.TIPS.2004.06.002
P577
2004-08-01T00:00:00Z